Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Implementing a cluster-RCT of a community pharmacist-led intervention to support consumers living with severe and persistent mental illness: bridging the gap between physical and mental illness (PharMIbridge)

  • At: Seville (Spain) (2022)
  • Type: Poster
  • Poster code: SAP-011
  • By: COLLINS, Jack (The University Of Sydney School of Pharmacy, The University of Sydney, Australia)
  • Co-author(s):

    Dr Jack Collins, Postdoctoral Research Associate (The University Of Sydney School of Pharmacy, The University of Sydney, Sydney, Australia)
    Prof Amanda Wheeler, Menzies Health Institute Queensland (Menzies Health Institute Queensland, Griffith University, Brisbane, Australia / Faculty of Medical and Health Sciences, Auckland Unviersity, Auckland, New Zealand)
    Dr SARIRA El-Den (The University Of Sydney School of Pharmacy, The University of Sydney, Sydney, Australia)
    Dr Sara McMillan, School of Pharmacy and Medical Sciences (Menzies Health Institute Queensland, Griffith University, Brisbane, Australia / School of Pharmacy and Medical Sciences, Griffith University, Gold Coast, Australia)
    Dr Jie Hu, Menzies Health Institute Queensland (Menzies Health Institute Queensland, Griffith University, Brisbane, Australia)
    Ms Helena Roennfeldt, Menzies Health Institute Queensland (Menzies Health Institute Queensland, Griffith University, Brisbane, Australia / Centre for Psychiatric Nursing, University of Melbourne, Melbourne, Australia)
    Ms Ricki Ng, The University of Sydney School of Pharmacy (The University Of Sydney School of Pharmacy, The University of Sydney, Sydney, Australia)
    Ms Victoria Stewart, Menzies Health Institute Queensland (Menzies Health Institute Queensland, Griffith University, Brisbane, Australia)
    Dr Claire O'Reilly, The University of Sydney School of Pharmacy (The University Of Sydney School of Pharmacy, The University of Sydney, Sydney, Australia)


  • Abstract:

    Background information: There is a significant life expectancy gap between consumers living with severe and persistent mental illness (SPMI; e.g. schizophrenia, bipolar disorder) and the general population, partially attributable to physical comorbidities. As one of the most accessible healthcare professionals and with medications forming the

    ..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses